Adagio Medical Holdings (ADGM) Gains from Investment Securities (2023 - 2026)
Adagio Medical Holdings (ADGM) posted Gains from Investment Securities of $131000.0 for Q1 2026, up 137.01% sequentially from -$354000.0 in Q4 2025, and up 444.74% YoY from $24048.3 in Q1 2025.
Adagio Medical Holdings (ADGM) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Adagio Medical Holdings has reported Gains from Investment Securities for 4 years, with the latest figure at $131000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 444.74% year-over-year to $131000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149000.0 (up 102.97% YoY) and the FY2025 annual result came in at -$20000.0, up 99.7% from the prior year.
- Gains from Investment Securities advanced to $131000.0 in Q1 2026 per ADGM's latest filing, from -$354000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $231000.0 in Q3 2025 and troughed at -$5.0 million in Q3 2024.
- A 4-year average of -$489400.0 and a median of -$7500.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2026: Gains from Investment Securities tumbled 21721.74% in 2024, then jumped 444.74% in 2026.
- Over 4 years, Gains from Investment Securities stood at -$41000.0 in 2023, then slumped by 12029.27% to -$5.0 million in 2024, then soared by 92.88% to -$354000.0 in 2025, then surged by 137.01% to $131000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $131000.0, -$354000.0, and $231000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Adagio Medical Holdings | 14.11 Mn | 14.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -181,000.00 |
| Jun 30, 2026 | -181,000.00 |
| Mar 31, 2026 | 131,000.00 |
| Mar 31, 2026 | 131,000.00 |
| Dec 31, 2025 | -354,000.00 |
| Dec 31, 2025 | -354,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -94,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |